Novel low temperature setting nanocrystalline calcium phosphate cements for bone repair: Osteoblast cellular response and gene expression studies
Source abstract
Abstract
Abstract Low temperature setting calcium phosphate cements (CPC) formed from reactive calcium phosphate precursors are receiving great attention in the fields of orthopaedics and tissue engineering. The purpose of this study was to evaluate the mechanical properties and osteocompatibility of a novel calcium deficient hydroxyapatite (CDSHA) with a Ca/P ratio of 1.6 developed in our laboratories and compare it to a previously developed calcium deficient hydroxyapatite (CDHA) with a Ca/P ratio of 1.5. The results demonstrated that the calcium‐deficient hydroxyapatites (HA) formed from the CPCs were similar to biological HA at physiological temperature and the elastic moduli of CDHA and CDSHA were found to be 174.42 ± 20.41 MPa (p < 0.05) and 115.86 ± 24.8 MPa (p < 0.05), respectively. The surface morphologies of the two calcium deficient HA's formed were identical with a micro/nano porous structure as evidenced from SEM. The cellular proliferation on CDHA, and CDSHA, was comparable to the control, tissue culture polystyrene (TCPS) (p < 0.05). Alkaline phosphatase activity was significantly elevated on CDHA and CDSHA matrices at early time points when compared with the control (TCPS) (p < 0.05). Osteoblast cells gene expression on CDHA, and CDSHA showed type I collagen, alkaline phosphatase, osteocalcin, and osteopontin activity at both 7 and 14 days of culture. Thus, novel calcium‐deficient HAs, CDHA, and CDSHA formed at low temperature are promising candidates for orthopaedic applications based on their ability to promote osteoblast cell adhesion and gene expression in vitro. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2007
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Calcium Carbonate Crystallization and Inhibition
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. 10.1016/S0927-796X(01)00035-310.1016/S0927-796X(01)00035-3 ↗
2. 10.1097/00003086-198606000-0004610.1097/00003086-198606000-00046 ↗
3. 10.1097/00003086-198106000-0003710.1097/00003086-198106000-00037 ↗
4. Shors EC · 1993
5. 10.1126/science.789260310.1126/science.7892603 ↗
6. Brown WE · 1987
7. 10.1097/00005131-198909000-0000210.1097/00005131-198909000-00002 ↗
8. BrownWE ChowLC. Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements. US Patent No. 4 612 053 1986.
9. 10.1002/jbm.1022210.1002/jbm.10222 ↗
10. 10.1016/S0020-1383(00)80022-410.1016/S0020-1383(00)80022-4 ↗
11. 10.1016/j.biomaterials.2003.10.06610.1016/j.biomaterials.2003.10.066 ↗
12. 10.1177/0022034597076004120110.1177/00220345970760041201 ↗
13. A coralline hydroxyapatite bone graft substitute10.1097/00003086-198409000-00036 ↗
14. 10.1002/(SICI)1097-4636(1999)48:1<36::AID-JBM8>3.0.CO;2-I10.1002/(SICI)1097-4636(1999)48:1<36::AID-JBM8>3.0.CO;2-I ↗
15. 10.1002/jps.260081061110.1002/jps.2600810611 ↗
16. 10.1016/B0-08-043152-6/00170-410.1016/B0-08-043152-6/00170-4 ↗
17. BrownWE ChowLC. Dental Restorative Cement Pastes. US Patent No. 4 518 430 1985.
18. 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q ↗
19. 10.1002/(SICI)1097-4636(19981205)42:3<403::AID-JBM8>3.0.CO;2-N10.1002/(SICI)1097-4636(19981205)42:3<403::AID-JBM8>3.0.CO;2-N ↗
20. 10.1002/1097-4636(200010)52:1<95::AID-JBM12>3.0.CO;2-X10.1002/1097-4636(200010)52:1<95::AID-JBM12>3.0.CO;2-X ↗
21. 10.1002/1097-4636(20010305)54:3<344::AID-JBM50>3.0.CO;2-110.1002/1097-4636(20010305)54:3<344::AID-JBM50>3.0.CO;2-1 ↗
22. 10.1023/A:100892110408010.1023/A:1008921104080 ↗
23. 10.1016/S0099-2399(97)80307-X10.1016/S0099-2399(97)80307-X ↗
24. 10.1016/0022-0248(95)00994-910.1016/0022-0248(95)00994-9 ↗
25. 10.1007/BF0015454110.1007/BF00154541 ↗
26. Hydration of tetracalcium phosphate
27. 10.1002/(SICI)1097-4636(19970605)35:3<299::AID-JBM4>3.0.CO;2-C10.1002/(SICI)1097-4636(19970605)35:3<299::AID-JBM4>3.0.CO;2-C ↗
28. 10.1016/j.biomaterials.2004.02.03910.1016/j.biomaterials.2004.02.039 ↗
29. 10.1016/0092-8674(81)90037-410.1016/0092-8674(81)90037-4 ↗
30. 10.1210/edrv-14-4-42410.1210/edrv-14-4-424 ↗
31. 10.1002/(SICI)1097-4644(19990915)74:4<616::AID-JCB11>3.0.CO;2-Q10.1002/(SICI)1097-4644(19990915)74:4<616::AID-JCB11>3.0.CO;2-Q ↗
32. 10.1016/8756-3282(95)00183-E10.1016/8756-3282(95)00183-E ↗
33. 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A ↗
34. 10.1002/jbm.a.2002110.1002/jbm.a.20021 ↗
35. 10.1002/jbmr.565007021610.1002/jbmr.5650070216 ↗
36. 10.1007/s00223990039710.1007/s002239900397 ↗
37. Properties of the depolarization activated calcium and barium entry in osteoblast‐like cells10.1016/S0021-9258(17)31243-7 ↗
38. 10.1002/1097-4636(20001205)52:3<460::AID-JBM3>3.0.CO;2-U10.1002/1097-4636(20001205)52:3<460::AID-JBM3>3.0.CO;2-U ↗
39. 10.1002/(SICI)1097-4644(1998)72:30/31 <92::AID-JCB13>3.0.CO;2-A10.1002/(SICI)1097-4644(1998)72:30/31 <92::AID-JCB13>3.0.CO;2-A ↗